These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 34812534)
1. Expression and prognostic significance of m6A-related genes in TP53-mutant non-small-cell lung cancer. Zhao Z; Wan J; Guo M; Wang Y; Yang Z; Zhou F; Li Z; Ming L J Clin Lab Anal; 2022 Jan; 36(1):e24118. PubMed ID: 34812534 [TBL] [Abstract][Full Text] [Related]
2. The pathological tissue expression pattern and clinical significance of m6A-regulatory genes in non-small cell lung cancer. Li Y; Zhang X; Cai J; Ren L; Liu B; Wu M; Lu W; Li R; Zhang C; Huang C; Tong J; Liu A; Zheng Y; Ren D; Guo Y; Huang Y J Gene Med; 2022 Feb; 24(2):e3397. PubMed ID: 34751492 [TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of the prognostic value of TP53 dependent etoposide-induced gene 24 in non-small cell lung cancer. Wang M; Li P; Wan R; Liu X Biomed Pharmacother; 2019 Apr; 112():108590. PubMed ID: 30784913 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer. Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014 [TBL] [Abstract][Full Text] [Related]
5. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer. Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164 [TBL] [Abstract][Full Text] [Related]
6. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer. Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
8. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis. Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079 [TBL] [Abstract][Full Text] [Related]
9. Characterizing m6A modification factors and their interactions in colorectal cancer: implications for tumor subtypes and clinical outcomes. Sun W; Su Y; Zhang Z Discov Oncol; 2024 Sep; 15(1):457. PubMed ID: 39292326 [TBL] [Abstract][Full Text] [Related]
10. M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer. Liu X; Ma C; Liu H; Sun Z; Luo J J Cancer Res Clin Oncol; 2022 Oct; 148(10):2803-2814. PubMed ID: 35596010 [TBL] [Abstract][Full Text] [Related]
11. Identification of pathology-specific regulators of m Li N; Zhan X EPMA J; 2020 Sep; 11(3):485-504. PubMed ID: 32849929 [TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X Front Genet; 2022; 13():872186. PubMed ID: 35937991 [No Abstract] [Full Text] [Related]
13. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma. Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of TP53 and its correlation with EGFR mutation in advanced non-small cell lung cancer, an analysis based on cBioPortal data base. Jiao XD; Qin BD; You P; Cai J; Zang YS Lung Cancer; 2018 Sep; 123():70-75. PubMed ID: 30089598 [TBL] [Abstract][Full Text] [Related]
15. Prognostic and therapeutic implication of m6A methylation in Crohn disease. He Y; Hu Y; Yuan M; Xu W; Du Y; Liu J Medicine (Baltimore); 2022 Dec; 101(51):e32399. PubMed ID: 36595818 [TBL] [Abstract][Full Text] [Related]
16. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment. Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566 [TBL] [Abstract][Full Text] [Related]
17. Investigating the prognostic value of m6A methylation-related genes in renal cell carcinoma patients. Ge GC; Wang CH Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):11932-11946. PubMed ID: 38164857 [TBL] [Abstract][Full Text] [Related]
18. Expression patterns and prognostic role of m6A RNA methylation regulators in Non-small Cell Lung Cancer. Zhang M; Yang C; Dong W; Zhao Y; Chen N; Gao C Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):67-72. PubMed ID: 38430042 [TBL] [Abstract][Full Text] [Related]
19. m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma. Li F; Wang H; Huang H; Zhang L; Wang D; Wan Y Front Genet; 2020; 11():994. PubMed ID: 33193582 [TBL] [Abstract][Full Text] [Related]
20. Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer. Chen Y; Chen G; Li J; Huang YY; Li Y; Lin J; Chen LZ; Lu JP; Wang YQ; Wang CX; Pan LK; Xia XF; Yi X; Chen CB; Zheng XW; Guo ZQ; Pan JJ JAMA Netw Open; 2019 Sep; 2(9):e1911895. PubMed ID: 31539077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]